Primary angle-closure glaucoma is a leading cause of vision loss, affecting an estimated 20 million people. Dr. Lori Provencher sits down with Dr. Benjamin Xu to discuss the research from his article, “Rates and Patterns of Diagnostic Conversion from Anatomical Narrow Angle to Primary Angle-Closure Glaucoma in the United States.”

After briefly reviewing angle-closure terminology, Dr. David Friedman shares 4 myths about managing angle-closure patients in this presentation from Glaucoma Subspecialty Day 2022.

Recommendations distilled from the PPPs for the diagnosis and management of primary open-angle glaucoma, primary open-angle glaucoma suspect, and primary angle-closure disease

To dilate or not to dilate, that is the question Dr. Lori Provencher poses to Dr. David S. Friedman as they discuss the results of his Ophthalmology Glaucoma article “Acute Angle-Closure Attacks Are Uncommon in Primary Angle-Closure Suspects after Pharmacologic Mydriasis.”

This week in the news, virtual eye triage assessments prevent ED visits, statins offer no extra protection against glaucoma, and visual impairment increases the risk of cognitive decline.

This study identified anterior segment OCT biometric parameters that are risk factors for progression from primary angle-closure suspect to more severe disease.

Dr. Sharon L. Jick continues to discuss glaucoma topics in a 3-part series for comprehensive ophthalmologists.

In this 1-Minute Video, Dr. Ron Fellman discusses how to manage angle-closure glaucoma.

This prospective randomized trial evaluated the efficacy of phacoemulsification combined with either endocycloplasty (ECPL) or trabeculectomy for primary angle-closure glaucoma.